The decrease of vWF antigen content in AML patients indicates the presence of a small amount of vascular endothelial cell activation and thrombosis or the absence of thrombosis and also indicates the reduction of AML stimulation to AML patients. The gene discussed is VWF; the disease is acute myeloid leukemia.